Covista Inc. (ATGE) Form 8-K — Aug 6, 2026
Covista Inc. reported fiscal year 2026 results (ended June 30, 2026) that exceeded its financial guidance, with revenue of $1,954.1 million, up 9.3% year-over-year, GAAP diluted EPS of $7.04, and adjusted EPS of $8.25, up 23.7% year-over-year. Full-year adjusted EBITDA rose 13.5% to $521.7 million on GAAP net income of $251.6 million. Fourth quarter revenue was $501.4 million, up 9.7% year-over-year, with adjusted EPS of $2.09, up 25.9%.
Key figures
- Eps
- $7.04 GAAP diluted (FY2026); $2.06 (Q4 FY2026)
- Revenue
- $1,954.1 million (FY2026)
- Guidance
- FY2027 revenue $2,050-$2,090 million (+5-7% YoY); adjusted EPS $8.90-$9.15 (+8-11% YoY)
- Net Income
- $251.6 million (FY2026); $71.7 million (Q4 FY2026)
- Total Debt
- $673.0 million total long-term debt principal
- Revenue Yoy
- 9.3%
- Total Assets
- $3,012.7 million (June 30, 2026)
- Cash Position
- $406.3 million (June 30, 2026)
- Net debt
- $266.7 million
- Q4 revenue
- $501.4 million, +9.7% YoY
- Net leverage
- 0.5x
- Fy adjusted eps
- $8.25, +23.7% YoY
- Q4 adjusted eps
- $2.09, +25.9% YoY
- Fy free cash flow
- $393.1 million
- Walden enrollment
- 54,851, +14.0% YoY, highest in university history
- Fy adjusted ebitda
- $521.7 million, +13.5% YoY
- Q4 adjusted ebitda
- $126.9 million, +15.2% YoY
- Q4 total enrollment
- 99,472, +8.4% YoY, 12th straight quarter of growth
- Term loan b repayment
- $50 million
- Chamberlain enrollment
- 39,501, +1.6% YoY
- Fy2026 share repurchases
- $238 million
- Medical veterinary enrollment
- 5,120, +7.3% YoY
Price after filing
1 day: -0.8%7 days: +1.5%30 days: -1.4%
Close on the filing date to close N calendar days later (from $129.89). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.